Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Immunology Letters
|
December 17, 2017
Chemokines in systemic sclerosis
Jamie King, David Abraham, Richard Stratton
Cells
|
July 11, 2025
Understanding the Role of Epithelial Cells in the Pathogenesis of Systemic Sclerosis
Lydia Nagib, Anshul Sheel Kumar, Richard Stratton
Rheumatology (Oxford, England)
|
December 6, 2020
First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors
Arianna E Azari, Richard Stratton, Animesh Singh
Experimental Dermatology
|
June 28, 2020
Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3p
John Henderson, Stefan Pryzborski, Richard Stratton, et al.
Journal of the Royal Society of Medicine
|
June 2, 2005
Use of rituximab in two unusual antibody-mediated autoimmune disorders
Matthew Adler, Fotini Soliotis, Sonali Thakrar, et al.
Body Image
|
August 16, 2015
Don't stop till you get enough: Factors driving men towards muscularity
Richard Stratton, Caroline Donovan, Shannon Bramwell, et al.
Plos One
|
July 29, 2015
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin
Joanna Nikitorowicz-Buniak, Christopher P Denton, David Abraham, et al.
Epigenetics
|
September 23, 2020
microRNA27a-3p mediates reduction of the Wnt antagonist sFRP-1 in systemic sclerosis
John Henderson, Sarah Wilkinson, Stefan Przyborski, et al.
Journal of the Royal Society of Medicine
|
September 10, 2008
Palmar fasciitis and polyarthritis syndrome: a sign of ovarian malignancy
Mahinda Yogarajah, Jade Soh, Breck Lord, et al.
Current Opinion in Infectious Diseases
|
June 18, 2009
Autoimmunity and HIV
Richard Stratton, Gabrielle Slapak, Tabitha Mahungu, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Immunology Letters
|
December 17, 2017
Chemokines in systemic sclerosis
Jamie King, David Abraham, Richard Stratton
Cells
|
July 11, 2025
Understanding the Role of Epithelial Cells in the Pathogenesis of Systemic Sclerosis
Lydia Nagib, Anshul Sheel Kumar, Richard Stratton
Rheumatology (Oxford, England)
|
December 6, 2020
First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors
Arianna E Azari, Richard Stratton, Animesh Singh
Experimental Dermatology
|
June 28, 2020
Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3p
John Henderson, Stefan Pryzborski, Richard Stratton, et al.
Journal of the Royal Society of Medicine
|
June 2, 2005
Use of rituximab in two unusual antibody-mediated autoimmune disorders
Matthew Adler, Fotini Soliotis, Sonali Thakrar, et al.
Body Image
|
August 16, 2015
Don't stop till you get enough: Factors driving men towards muscularity
Richard Stratton, Caroline Donovan, Shannon Bramwell, et al.
Plos One
|
July 29, 2015
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin
Joanna Nikitorowicz-Buniak, Christopher P Denton, David Abraham, et al.
Epigenetics
|
September 23, 2020
microRNA27a-3p mediates reduction of the Wnt antagonist sFRP-1 in systemic sclerosis
John Henderson, Sarah Wilkinson, Stefan Przyborski, et al.
Journal of the Royal Society of Medicine
|
September 10, 2008
Palmar fasciitis and polyarthritis syndrome: a sign of ovarian malignancy
Mahinda Yogarajah, Jade Soh, Breck Lord, et al.
Current Opinion in Infectious Diseases
|
June 18, 2009
Autoimmunity and HIV
Richard Stratton, Gabrielle Slapak, Tabitha Mahungu, et al.
Page
of 6